SurvodutideNew
AC-WL-105

Survodutide

Weight Loss & MetabolicPurity: 99%

Dual GLP-1/Glucagon receptor agonist studied for energy expenditure, fat oxidation, and metabolic homeostasis pathway modulation in preclinical research.

1
Dual GLP-1/Glucagon receptor agonist studied for energy expenditure, fat oxidation, and metabolic homeostasis pathway modulation in preclinical research.